Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
DSIP A naturally occurring neuropeptide first isolated during slow-wave sleep, researched for sleep regulation, stress responses, pain perception, and potential applications in depression and substance withdrawal
GHKCu Foam for Women No long-term contracts Personalized plans On-demand medical support Free expedited shipping *Price includes medication only, if prescribed
Yes, coverage extends to every province and to Yukon, the Northwest Territories, and Nunavut
You are pregnant